These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26265267)

  • 1. Experimental autoimmune encephalomyelitis is a good model of multiple sclerosis if used wisely.
    Baker D; Amor S
    Mult Scler Relat Disord; 2014 Sep; 3(5):555-64. PubMed ID: 26265267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EAE is not a useful model for demyelinating disease.
    Behan PO; Chaudhuri A
    Mult Scler Relat Disord; 2014 Sep; 3(5):565-74. PubMed ID: 26265268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development.
    Ben-Nun A; Kaushansky N; Kawakami N; Krishnamoorthy G; Berer K; Liblau R; Hohlfeld R; Wekerle H
    J Autoimmun; 2014 Nov; 54():33-50. PubMed ID: 25175979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune pathogenesis of experimental autoimmune encephalomyelitis: lessons learned for multiple sclerosis?
    Kuerten S; Lehmann PV
    J Interferon Cytokine Res; 2011 Dec; 31(12):907-16. PubMed ID: 21936633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis: human model for EAE?
    Hohlfeld R
    Eur J Immunol; 2009 Aug; 39(8):2036-9. PubMed ID: 19672899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multiple sclerosis and experimental autoimmune encephalomyelitis].
    Béraud-Juven E
    Rev Prat; 1994 Jan; 44(1):69-74. PubMed ID: 8178062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EAE: imperfect but useful models of multiple sclerosis.
    't Hart BA; Gran B; Weissert R
    Trends Mol Med; 2011 Mar; 17(3):119-25. PubMed ID: 21251877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.
    Martin R; McFarland HF
    Crit Rev Clin Lab Sci; 1995; 32(2):121-82. PubMed ID: 7598789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Thamilarasan M; Koczan D; Hecker M; Paap B; Zettl UK
    Autoimmun Rev; 2012 Jan; 11(3):174-9. PubMed ID: 21621006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling of multiple sclerosis: lessons learned in a non-human primate.
    't Hart BA; Laman JD; Bauer J; Blezer E; van Kooyk Y; Hintzen RQ
    Lancet Neurol; 2004 Oct; 3(10):588-97. PubMed ID: 15380155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The translation of drug efficacy from in vivo models to human disease with special reference to experimental autoimmune encephalomyelitis and multiple sclerosis.
    Bolton C
    Inflammopharmacology; 2007 Oct; 15(5):183-7. PubMed ID: 17943249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental autoimmune encephalomyelitis].
    Cornet A; Vizler C; Liblau R
    Rev Neurol (Paris); 1998 Sep; 154(8-9):586-91. PubMed ID: 9809373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of EAE to understanding and treating multiple sclerosis.
    Lovett-Racke AE
    J Neuroimmunol; 2017 Mar; 304():40-42. PubMed ID: 27544641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).
    Ziemssen T; Ziemssen F
    Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.
    Emerson MR; Gallagher RJ; Marquis JG; LeVine SM
    Comp Med; 2009 Apr; 59(2):112-28. PubMed ID: 19389303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis.
    Zhang X; Hupperts R; De Baets M
    Immunol Res; 2003; 28(1):61-78. PubMed ID: 12947225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.
    Steinman L; Zamvil SS
    Trends Immunol; 2005 Nov; 26(11):565-71. PubMed ID: 16153891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-based modulation of autoimmune responses in multiple sclerosis and experimental autoimmmune encephalomyelitis: therapeutic implications.
    Mastorodemos V; Ioannou M; Verginis P
    Neuroimmunomodulation; 2015; 22(3):181-95. PubMed ID: 24852748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Of mice and men: experimental autoimmune encephalitis and multiple sclerosis.
    Handel AE; Lincoln MR; Ramagopalan SV
    Eur J Clin Invest; 2011 Nov; 41(11):1254-8. PubMed ID: 21418205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.
    Kassis I; Petrou P; Halimi M; Karussis D
    Immunol Lett; 2013; 154(1-2):70-6. PubMed ID: 23994102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.